VistaPath Biosystems, Inc.

CAMBRIDGE, MA · Founded 2017 · Medtech · Private

Sentinel Platform for digital histology and pathology analysis

Claim this profile

Follows are private to you and power your alerts

Updated · vistapath.ai

Sector
Medtech
Headquarters
CAMBRIDGE, MA
Founded
2017
Latest Form D
$4.4M, Jul 2023
Total capital
$11.3M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$11.3M
6 Form D · last Jul 2023
40 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
3 pending · first 2020
Rank in peer group#29 of 73

Capital timeline

20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $11.3M1st Form D$225K2nd Form D$170K4th Form D$5.3M6th Form D$4.4M
20192020202120222023FEDERAL ↑EQUITY ↓Cumulative $11.3M

Latest events

  • Private capital raisedForm D · SEC · 6th filing$4.4M
  • Private capital raisedForm D · SEC · 5th filing$1M
  • Private capital raisedForm D · SEC · 4th filing$5.3M
  • Private capital raisedForm D · SEC · 3rd filing$100K
  • Private capital raisedForm D · SEC · 2nd filing$170K
  • Private capital raisedForm D · SEC · 1st filing$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 73 peers

Line = median

Medtech · Platform

  • Granted patents#29 · top 40%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Spong TimothyResearcherExecutive Officer, DirectorLinked by 1 patent
  • Timothy SpongResearcherExecutive Officer, DirectorLinked by 1 patent
  • Benjamin BurleyExecutive Officer, DirectorNamed in SEC Form D filings
  • Burley BenjaminExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 4
Show all 4 patent records
  • Apparatus and Methods for Processing and Cataloging of SamplesJul 23, 2020 · Application 16841919Pending
  • Apparatus and Methods for Processing and Cataloging of SamplesJun 16, 2020 · US 10,684,295Granted
  • Apparatus And Methods For Processing And Cataloging Of SamplesApplication PCTUS2019039229Pending
  • Apparatus and Method for Processing and Cataloging of SamplesApplication 62694093Pending
  • MILESTONE SCIENTIFIC INC.Similar federal contract value in Medtech · null in contracts
  • Spartan Bioscience Inc.Similar federal contract value in Medtech · null in contracts
  • NOVIAN HEALTH INC.Similar federal contract value in Medtech · null in contracts
  • Koya Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • ActX, Inc.Similar federal contract value in Medtech · null in contracts
  • Sylke, Inc.Similar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .